Speaker Profile

Site Head & VP of Cell Therapy Manufacturing , BMS

Biography
Chris leads day to day commercial CAR-T manufacturing operations at the BMS site in Bothell, delivering autologous therapies to patients globally. He also works with the company’s larger cell therapy network to set the strategic direction for the site, to maximize the reach of commercially available cell therapies for patients and support the growth of its cell therapy pipeline. Chris is a chemist, turned engineer with 25+ years of experience working in the Pharma, Biologics & CGT sectors. After starting and growing his career in Europe, he has spent the last 10 years in the US in a variety of leadership roles in manufacturing operations.


 Session Abstract – PMWC 2023 Silicon Valley

Track 1 - January 26 9.00 A.M.-4.30 P.M.


Track Chair: Sharon Benzeno, Adaptive Biotechnologies

  • PMWC 2023 Luminary Award Ceremony
    Honoree: Bruce Levine, University of Pennsylvania
  • Advance and Optimize Cell Therapies in Oncology (PANEL)
    Chair: Sharon Benzeno, Adaptive Biotechnologies
    - Ira Mellman, Genenetch
    - Lewis “Rusty” Williams, Walking Fish Therapeutics
    - Loïc VINCENT, Affini-T Therapeutics
    - Nick Haining, Arsenal
  • Pioneering Cell Therapies in the Treatment of Autoimmune Disorders (PANEL)
    Chair: Carl June, UPenn
    - Lenny Dragone, Sonoma
    - James Chung, Kyverna
    - David Chang, Cabaletta
    - Cristina Musselli, Abata Therapeutics
  • Innovations in Cell Therapy Manufacturing (PANEL)
    Chair: Bruce Levine, University of Pennsylvania
    - Chris Holt, BMS
    - Heidi Hagen, Sonoma Bio
    - Rahul Singhvi, Resilience
    - Snehal Patel, Sana Biotechnology
  • Patentability of Immunotherapies - Latest Developments
    - Janet Xiao, Morrison & Foerster LLP
  • Leveraging Data Sets to Inform Future Drug Discovery and Development (PANEL)
    Chair: Jason Coloma, Maze Therapeutics
    - Peter DiLaura, Sonoma Bio
    - Nick Haining, Arsenal
    - Ulrik Nielsen, Sanofi
    - Lacey Padron, Parker Institute